Skip to Main Content

Paper Details

Plasma cell-free RNA profiling distinguishes cancers from pre-malignant conditions in solid and hematologic malignancies.
NPJ Precis Oncol
19
2022
-, Cell-free RNA, HCC, MM, Plasma cell, Plasma cfRNA, cancer, cancers, cfRNA, free RNA, gene sets, hepatocellular carcinoma, liver-specific genes, mRNA, mRNA transcripts, messenger RNA, multiple myeloma, noncancerous states, patients, plasma, pre-malignant conditions, precancerous, precancerous conditions, premalignant conditions, solid and hematologic malignancies
Author NameAffiliation
Pavana AnurCancer Early Detection Advanced Research Center (CEDAR), Knight Cancer Institute, Oregon Health and Science University
Paul T SpellmanCancer Early Detection Advanced Research Center (CEDAR), Knight Cancer Institute, Oregon Health and Science University
Paul T SpellmanOregon Health and Science University
Paul T SpellmanOregon Health and Science University
Paul T SpellmanCancer Early Detection Advanced Research Center (CEDAR), Knight Cancer Institute, Oregon Health and Science University
Paul T SpellmanOregon Health and Science University
Paul T SpellmanOregon Health and Science University
Reid F ThompsonCancer Early Detection Advanced Research Center (CEDAR), Knight Cancer Institute, Oregon Health and Science University
Reid F ThompsonOregon Health and Science University
Reid F ThompsonOregon Health and Science University
Reid F ThompsonOregon Health and Science University
Reid F ThompsonDivision of Hospital and Specialty Medicine, VA Portland Healthcare System
  • 1 - 12

Datasets

Release 1.2